US › Healthcare

Psyence Biomedical Ltd. Common Shares (PBM)

US · Healthcare · Biotechnology

$3.19+1.27%

Last close · 2026-08-04

Latest quarter · ended 2025-09-30

Revenue

Net profit

$-753,254

Profit YoY

+14.1%

EPS

$-0.51

EPS estimate

$0.00

Key statistics

Market cap

$12.8M

Forward P/E

0.0

P/B

0.72

Book value

$7.39

EPS (TTM)

$-12.56

52-week high

$34.62

52-week low

$1.92

50-day MA

$3.31

200-day MA

$27.69

Beta

1.68

Shareholding

Insiders

2.97%

Institutions

4.02%

Largest institutional holders

Fund	Stake
Parallel Advisors, LLC	3.97%
Stonehage Fleming Financial Services Holdings Ltd	0.00%
Bank of America Corp	0.00%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Psyence Biomedical Ltd. Common Shares — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.